Investigators at University of Paris Saclay Discuss Findings in Antivirals [Plasma Concentrations of Antiretroviral Drugs In a Successful <break/>4-days-a-week Maintenance Treatment Strategy In Hiv-1 Patients (Anrs 170-quatuor Trial)].
In: Drug Week, 2024-05-24, S. 143-143
serialPeriodical
Zugriff:
Researchers at the University of Paris Saclay have conducted a study on the plasma concentrations of antiretroviral drugs in a 4-days-a-week maintenance treatment strategy for HIV-1 patients. The study compared two groups of patients, one receiving triple therapy for 4 days and then 3 days off (4/7), and the other receiving continuous therapy (7/7). The results showed that the 4/7-day treatment option led to antiretroviral blood levels similar to continuous treatment after four consecutive days of medication, and lower levels at the end of the non-treatment period. The research was supported by the Agence Nationale de recherche sur le Sida et les hepatites virales (ANRS) and the Institut Nationale de la Sante et de la Recherche Medicale (INSERM). [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Investigators at University of Paris Saclay Discuss Findings in Antivirals [Plasma Concentrations of Antiretroviral Drugs In a Successful <break/>4-days-a-week Maintenance Treatment Strategy In Hiv-1 Patients (Anrs 170-quatuor Trial)].
|
---|---|
Zeitschrift: | Drug Week, 2024-05-24, S. 143-143 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|